These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13847023)

  • 21. Cerebrospinal fluid N-acetyl neuraminic acid in Parkinson's disease, before and after L-dopa therapy.
    Lipman IJ; Papadopoulos NM
    Dis Nerv Syst; 1973 Jan; 34(1):59-62. PubMed ID: 4709194
    [No Abstract]   [Full Text] [Related]  

  • 22. Cerebrospinal fluid glycoproteins in schizophrenia.
    Campbell RJ; Bogoch S; Scolaro MJ; Belval PC
    Am J Psychiatry; 1967 Feb; 123(8):952-62. PubMed ID: 5334886
    [No Abstract]   [Full Text] [Related]  

  • 23. [Characteristics of the cerebrospinal fluid space and of the cerebrospinal fluid pressure during therapeutic anoxia in mental patients treated by the present methods].
    GHERSI JA; PIACQUADIO N; MAYO F
    Rev Asoc Med Argent; 1953 Dec 15-30; 67(763-764):528-32. PubMed ID: 13155965
    [No Abstract]   [Full Text] [Related]  

  • 24. [ELECTROPHORETIC STUDIES ON CEREBROSPINAL FLUID PROTEINS IN MENTAL PATIENTS].
    NEMTSOVA M; KOUZHILEK K; ENGLISHOVA M
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1965; 65():73-5. PubMed ID: 14335755
    [No Abstract]   [Full Text] [Related]  

  • 25. Polar lipids and proteins in the cerebrospinal fluid.
    Clausen J; Fog T
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:649-64. PubMed ID: 5373046
    [No Abstract]   [Full Text] [Related]  

  • 26. Fractionation and quantitative analysis of cerebrospinal fluid constituents with reference to neuropsychiatric disorders.
    BOGOCH S
    Am J Psychiatry; 1958 May; 114(11):1028-9. PubMed ID: 13533632
    [No Abstract]   [Full Text] [Related]  

  • 27. Preliminary observations of gangliosides of normal and multiple sclerosis cerebrospinal fluid.
    Nagai Y; Kanfer JN; Tourtellotte WW
    Neurology; 1973 Sep; 23(9):945-8. PubMed ID: 4737686
    [No Abstract]   [Full Text] [Related]  

  • 28. Cerebrospinal fluid neuraminic acid deficiency in schizophrenia.
    BOGOCH S
    AMA Arch Neurol Psychiatry; 1958 Aug; 80(2):221-7. PubMed ID: 13558776
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood-cerebrospinal fluid bromide ratios in mental patients.
    COPPEN AJ
    J Neurol Neurosurg Psychiatry; 1959 Feb; 22(1):61-3. PubMed ID: 13642079
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunochemical measurement of gamma globulins in the cerebrospinal fluid in mental disorders].
    DELAY J; MOLLARET P; BURTIN P; LEMPERIERE T
    Ann Med Psychol (Paris); 1956 May; 114(5):834-9; discussion, 840. PubMed ID: 13340362
    [No Abstract]   [Full Text] [Related]  

  • 31. [Glycoproteins in the cerebrospinal fluid. VI. Glycoproteins in the cerebrospinal fluid in mental diseases].
    LANG BA; BROUCKOVA V; BLATAK F
    Acta Biol Med Ger; 1961; 7():96-105. PubMed ID: 14462034
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chromatographic studies of the amino acids of the cerebrospinal fluid in mental disorders].
    MAGHERINI G
    Rass Studi Psichiatr; 1954; 43(1):26-32. PubMed ID: 13167478
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuraminic acid as a constituent of human cerebrospinal fluid.
    RUMLEY MK; UZMAN LL
    Proc Soc Exp Biol Med; 1956 Dec; 93(3):497-501. PubMed ID: 13389499
    [No Abstract]   [Full Text] [Related]  

  • 34. Bial's reaction for neuraminic acid in cerebrospinal fluid from schizophrenics.
    JENNER FA; KERRY RJ; FOWLER DB; GRAVES EW
    J Ment Sci; 1962 Nov; 108():822-4. PubMed ID: 13957597
    [No Abstract]   [Full Text] [Related]  

  • 35. Cerebrospinal fluid neuraminic acid deficiency in schizophrenia; a preliminary report.
    BOGOCH S
    Am J Psychiatry; 1957 Aug; 114(2):172. PubMed ID: 13444485
    [No Abstract]   [Full Text] [Related]  

  • 36. STUDIES ON NEURAMINIC ACID IN THE CEREBROSPINAL FLUID IN SCHIZOPHRENIA.
    GREEN JP; ATWOOD RP; FREEDMAN DX
    Arch Gen Psychiatry; 1965 Jan; 12():90-5. PubMed ID: 14221697
    [No Abstract]   [Full Text] [Related]  

  • 37. [Gangliosides and neuraminic acids in multiple sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1971; 5(5):749-52. PubMed ID: 5003726
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of determination of sedimentation rate in cerebrospinal fluid and its clinical significance in neuro-psychiatry].
    D'ALBA A
    Minerva Med; 1955 Aug; 46(69):436-7. PubMed ID: 13265314
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunochemical determination of neurospecific beta 2-globulin in cerebrospinal fluid in mental disorders].
    Buĭlov VK; Lakosina ND; Tamarinov IuS; Terent'ev AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(7):1038-42. PubMed ID: 3898677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Research on the cerebrospinal fluid trypsin inhibitor in neurological and psychiatric patients].
    CANAL N; FRATTOLA L
    Boll Soc Ital Biol Sper; 1961 Jun; 37():496-8. PubMed ID: 13690354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.